Table 2 Clinical trials studies evaluating effect of vitamin D supplementation versus placebo in CAD patients.

From: Vitamin D supplementation effects on the clinical outcomes of patients with coronary artery disease: a systematic review and meta-analysis

  1. F female, M male, CAD coronary artery disease, I intervention group, P placebo group, IL interleukin, ICAM intercellular adhesion molecule; VCAM vascular cell adhesion protein, hs-CRP high-sensitivity C-reactive protein, TNF tumor necrosis factor, TC total cholesterol, TG triglyceride, LDL low density lipoprotein, HDL high density lipoprotein, SBP systolic blood pressure, DBP diastolic blood pressure, PTH parathyroid hormone.
Back to article page